Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Bone and Mineral Metabolism|March 28, 2024
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosisYoshiya Tanaka, Satoshi Soen, Shintaro Hirata, et al.JMA Journal|November 12, 2025
Sex Differences in Renal Outcomes and Metabolic Markers by Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Individuals with Type 2 Diabetes: A Post-Hoc Analysis of the RECAP StudyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.Journal of Diabetes Investigation|April 9, 2022
Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNAAsami Okada, Misuzu Yamada-Yamashita, Yukari Tominaga, et al.Diabetes & Vascular Disease Research|December 14, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medicationKazuo Kobayashi, Masao Toyoda, Atsuhito Tone, et al.Diabetes, Obesity & Metabolism|May 20, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease, Shunichiro Tsukamoto, Kazuo Kobayashi, et al.Frontiers in Pharmacology|April 11, 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP studyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.Pageof 6